Transfusion Therapy is Hazardous and Expensive, Yet Blood Utilization is Suboptimal!
- Blood acquisition costs have more than doubled in the past few years and will continue to rise as the blood supply struggles to meet the increasing demand.
- Each transfusion causes a stepwise increase in serious complications including postoperative infection rates, ventilator-acquired pneumonia, central line sepsis, ICU and hospital length of stay, as well as mortality rates.
- Transfusion costs exceed blood acquisition costs by four times or greater when accounting for labor, supplies, administration and adverse events.
- Most physicians who order blood products lack formal training in transfusion therapy, and many are unaware of current transfusion guidelines.
- Oversight of blood utilization is lacking as witnessed by wide variation in transfusion practices between institutions and among physicians at the same institution.
- From a medical-legal standpoint, the financial liability of improper informed consent, inappropriate transfusions and transfusion errors can can be substantial.
Results of Implementing a Blood Management Program
Actual Business Case Blood Management Program Cost Savings
750 Bed Community Hospital
Reduction in RBC transfusions 3500 units 17,500 units Blood acquisition cost savings* $735,000 $6,375,000 Transfusion cost savings $2,065,000 $10,325,000 Reduction in adverse events $4,200,000 $21,000,000 Total hospital cost savings** $7,000,000 $35,000,000 *RBC acquisition cost $210/ unit **Platelet cost savings adds $1.4M annual/ $7M over five years
Would you like to know how to solve the problem like this hospital? Contact me.